Andere Sprachen Amicus Therapeutics, Inc.

Aktien

A0MSMZ

US03152W1099

FOLD

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 07.06.2024			% 5 Tage	% 1. Jan.
10,05 ^USD	-2,14 %		+2,55 %	-29,18 %

30.05.	AMICUS THERAPEUTICS, INC. : Wells Fargo Securities gibt eine Kauf-Bewertung ab	ZM
15.05.	Transcript : Amicus Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference	05.06.
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) as Best Pharmaceutical Product	04.06.
Amicus Therapeutics' Q1 Net Loss Narrows, Net Product Sales Rise	09.05.
Amicus Therapeutics: Q1 Earnings Snapshot	09.05.
Amicus Therapeutics : 1Q24 Earnings Deck FINAL	09.05.
Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates	09.05.
Amicus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Amicus Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	09.05.
Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference	08.05.
Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024	01.05.
Amicus Therapeutics : ESG Report	20.03.
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report	20.03.
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing	05.03.
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	04.03.
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	01.03.
Amicus Therapeutics Swings to Q4 Earnings, Revenue Rises	28.02.
Earnings Flash (FOLD) AMICUS THERAPEUTICS Posts Q4 EPS $0.01, vs. Street Est of $-0.04	28.02.
Amicus Therapeutics, Inc. Provides Earnings Guidance for the Year 2024	28.02.
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates	28.02.
Amicus Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Amicus Therapeutics, Inc.

Aktien

A0MSMZ

US03152W1099

FOLD

Andere Sprachen

Filter